Indeed, over 110 different compounds, including metals, their oxides, metal salts, drugs, kinase inhibitors, endogenous toxins, inhibitors of signaling pathways, alkaloids and other plant-derived biologically active substances, have been shown to induce eryptosis in vitro at lower concentrations than hemolysis or to a higher extent at the same concentrations [450]
the Take-Away A new class of diabetes and weight-loss drugs is drawing attention from researchers, and the early data on opioid addiction may be the most compelling signal yet
In GLP-1s, both adverse effects and side effects primarily stem from their mechanisms of action, impacting multiple physiological systems, including the GI tract, pancreas, and central nervous system
Headache Headaches are a heterogeneous group of conditions characterized by intermittent or persistent pain, often described as pulsating or pressure-like
as Januvia) Vildagliptin [7] (EU approved in 2007, and marketed in the EU by Novartis as Galvus) Saxagliptin (FDA approved in 2009, and marketed as Onglyza) Linagliptin (FDA approved in 2011, and marketed as Tradjenta by Eli Lilly and Company and Boehringer Ingelheim) [8] Gemigliptin (approved in Korea in 2012, and marketed by LG Life Sciences as Zemiglo, among other names) [9] Anagliptin (approved in Japan as Suiny in 2012
